|
Market Closed -
Xetra
19:38:43 09/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 56.62 EUR | +1.87% |
|
+13.19% | +52.99% |
| 07:16am | Bayer Wins US FDA Approval for Sunharbo to Reduce Risk of Secondary Stroke in Adults | MT |
| 02:13am | Bayer's blood thinner Sunharbo also approved in the US | DP |
| Market Cap | 55.62B 62.32B 51.18B 46.45B 88.04B 5,841B 90.22B 612B 244B 3,127B 234B 229B 9,849B | P/E 2026 * |
26x | P/E 2027 * | 18.9x |
|---|---|---|---|---|---|
| Enterprise Value | 85.4B 95.68B 78.58B 71.32B 135B 8,968B 139B 940B 375B 4,801B 359B 351B 15,122B | EV / Sales 2026 * |
1.86x | EV / Sales 2027 * | 1.74x |
| Free-Float |
99.99% | Yield 2026 * |
0.25% | Yield 2027 * | 0.94% |
| Markets | Quality | ||
|---|---|---|---|
Xetra
| BAYN | Delayed | |
| BAYNd | Real-time | ||
| BAYN | Real-time | ||
| BAYN | Real-time | ||
| BAYN | Delayed | ||
| 1BAYN | End-of-day quote | ||
| BAYN | Delayed | ||
| BYR | Real-time | ||
| BYR | Delayed | ||
| BAYZF | Delayed | ||
| BAYN | End-of-day quote | ||
| BAYN | Delayed | ||
| BAYN N | End-of-day quote | ||
| BAYN | End-of-day quote | ||
| BAY | End-of-day quote | ||
| BAYER | Delayed | ||
| BAY | Delayed |
Last Transcript: Bayer AG
| 1 day | +1.87% | ||
| 1 week | +13.19% | ||
| Current month | +11.94% | ||
| 1 month | +29.36% | ||
| 3 months | +13.67% | ||
| 6 months | +53.11% | ||
| Current year | +52.99% |
| 1 week | 52.18 | 56.62 | |
| 1 month | 43.08 | 56.62 | |
| Current year | 32.96 | 56.62 | |
| 1 year | 26.3 | 56.62 | |
| 3 years | 18.38 | 56.62 | |
| 5 years | 18.38 | 67.99 | |
| 10 years | 18.38 | 123.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 60 | 01/06/2023 |
Judith Hartmann
DFI | Director of Finance/CFO | 57 | 01/06/2026 |
Christian Rommel
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/02/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
André van Broich
BRD | Director/Board Member | 56 | 01/04/2012 |
Heike Hausfeld
BRD | Director/Board Member | 61 | 01/04/2017 |
| Chairman | 69 | 28/04/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/18/26 A | Buy | Director | 1,900 | 0.0002% | ||
| 3/18/26 A | Buy | Executive/Senior Manager | 13,000 | 0.0013% | ||
| 3/18/26 A | Buy | Director | 1,500 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.87% | +13.19% | +117.31% | +35.44% | 60.88B | ||
| +4.28% | +0.07% | +52.75% | +138.78% | 1,206B | ||
| +2.13% | +4.27% | +51.21% | +91.36% | 665B | ||
| +0.68% | +1.54% | +33.83% | +112.47% | 515B | ||
| +2.77% | +0.98% | +49.44% | +68.46% | 381B | ||
| +1.38% | +0.27% | +72.42% | +45.30% | 362B | ||
| +0.29% | +1.48% | +30.84% | +58.32% | 307B | ||
| +0.98% | +1.49% | +9.04% | +34.78% | 289B | ||
| +1.04% | -0.05% | +45.29% | +76.18% | 249B | ||
| +1.46% | -0.59% | +42.48% | +125.82% | 207B | ||
| Average | +1.72% | +1.64% | +50.46% | +78.69% | 424B | |
| Weighted average by Cap. | +2.29% | +0.83% | +47.02% | +95.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 45.97B 51.5B 42.3B 38.39B 72.76B 4,827B 74.57B 506B 202B 2,584B 193B 189B 8,140B | 47.2B 52.88B 43.43B 39.42B 74.71B 4,957B 76.56B 520B 207B 2,654B 198B 194B 8,358B |
| Net income | 2.12B 2.37B 1.95B 1.77B 3.35B 222B 3.43B 23.28B 9.28B 119B 8.89B 8.7B 375B | 2.87B 3.22B 2.65B 2.4B 4.55B 302B 4.66B 31.65B 12.61B 162B 12.09B 11.83B 509B |
| Net Debt | 29.78B 33.36B 27.4B 24.87B 47.13B 3,127B 48.3B 328B 131B 1,674B 125B 123B 5,272B | 26.66B 29.87B 24.53B 22.27B 42.2B 2,800B 43.25B 294B 117B 1,499B 112B 110B 4,721B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/11/26 | €56.62 | +1.87% | 2,613,975 |
| 06/11/26 | €55.58 | -1.14% | 4,309,484 |
| 05/11/26 | €56.22 | +3.65% | 4,889,400 |
| 04/11/26 | €54.24 | +4.63% | 4,500,817 |
| 03/11/26 | €51.84 | +3.64% | 7,668,634 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- BAYN Stock
Select your edition
All financial news and data tailored to specific country editions
















